NBC Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
BPC
DLA
OIAM
YIH
CNB
COPPSERS
CUAMC
NBC Securities's MRNA Position: Q2 2026 in Review
NBC Securities reduced its Moderna (MRNA) stake by 43% in Q2 2026, selling an estimated $11.1K and leaving 279 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.
NBC Securities first reported a position in MRNA in Q3 2023 and has held it in 11 quarters since. The position peaked at $122K in Q1 2024. 184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- NBC Securities held 279 shares of Moderna worth $19.5K as of Q2 2026.
- NBC Securities sold 214 Moderna shares in Q2 2026, an estimated $11.1K.
- Moderna made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1663 holding.
- NBC Securities first reported a position in Moderna in Q3 2023 and has held it in 11 quarters since.
- NBC Securities's Moderna position peaked at $122K in Q1 2024.
- 184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.